Cholera Vaccine (Oral Recombinant) from Japan
Dukoral oral cholera vaccine contains inactivated Vibrio cholerae bacteria and recombinant B subunit for mucosal immunity. Falls under HTS 3002.49.00 as an 'other' vaccine via biotechnological processes. Administered as oral suspension for traveler's protection.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include proof of GMP manufacturing for oral biologics
• Separate from food products per Chapter 30 exclusion notes
• Validate expiry dates rigorously due to oral delivery sensitivity